Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1.41M | $6.0M | 5.07% | +1.38M | 2026-06-30 |
| Nantahala Capital Management, LLC | 1.40M | $6.0M | 5.03% | +462.2K | 2026-06-30 |
| DIADEMA PARTNERS LP | 1.10M | $5.0M | 3.94% | +990.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.07M | $5.0M | 3.85% | +260.1K | 2026-06-30 |
| Octagon Capital Advisors LP | 1.00M | $4.0M | 3.59% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 564.0K | $2.0M | 2.02% | +360.3K | 2026-06-30 |
| Vivo Capital, LLC | 550.0K | $2.0M | 1.97% | -1.24M | 2026-06-30 |
| MARSHALL WACE, LLP | 547.9K | $2.0M | 1.97% | +392.9K | 2026-06-30 |
| Caption Management, LLC | 530.0K | $2.0M | 1.90% | -- | 2026-06-30 |
| Logos Global Management LP | 473.6K | $2.0M | 1.70% | -- | 2026-06-30 |
